Agios Pharmaceuticals reported $0 in Debt for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Alexion Pharmaceuticals ALXN:US $ 2438.4M 31.6M
Alnylam Pharmaceuticals ALNY:US $ 0M 0M
Amgen AMGN:US $ 34224M 2376M
AstraZeneca AZN:LN 22339M 2592M
Bayer BAYN:GR € 41319M 1307M
Biogen BIIB:US $ 7425M 1.2M
Biomarin Pharmaceutical BMRN:US $ 1451.62M 589.81M
Bristol Myers Squibb BMY:US $ 46672M 34M
Daiichi Sankyo 4568:JP Y 224109M 42222M
Eli Lilly And LLY:US $ 16328.2M 902.1M
Gilead Sciences GILD:US $ 24102M 5M
GlaxoSmithKline GSK:LN 31690M 316M
Immunogen IMGN:US $ 0M 2.08M
JAZZ PHA JAZZ:US $ 2087.68M 15.37M
Merk MRK:US $ 30874M 2876M
Novartis NVS:US $ 38175M 3389M
Pfizer PFE:US $ 63613M 11325M
Puma Biotechnology PBYI:US $ 96M 1M
Regeneron Pharmaceuticals REGN:US $ 2215.9M 1500.7M
Sarepta Therapeutics SRPT:US $ 694M 7M
Seattle Genetics SGEN:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 522.07M 10.88M
YTE INCY:US $ 51.69M 0.3M